NCT02711137 2025-10-21Open-Label Safety and Tolerability Study of INCB057643 in Subjects With Advanced MalignanciesIncyte CorporationPhase 1/2 Terminated137 enrolled 31 charts
NCT00038246 2018-10-31Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate CarcinomaM.D. Anderson Cancer CenterPhase 1/2 Completed40 enrolled
NCT00003394 2013-06-24Combination Chemotherapy in Treating Patients With Advanced Prostate CancerMemorial Sloan Kettering Cancer CenterPhase 1/2 Completed18 enrolled
NCT00038168 2012-08-01Intravenous Estramustine With Taxol in Hormone Refractory Prostate AdenocarcinomaM.D. Anderson Cancer CenterPhase 1/2 Completed14 enrolled